Pharma & Healthcare

Deltex Medical Group Plc

Another Successful Learning Event Sponsored by Deltex

May 28th saw Deltex Medical Group supporting Current Initiatives, Research and the Role of Haemodynamic Monitoring at London’s Montague Hotel. Held under the auspices of the EBPOM organisation (Evidence Based PeriOperative Medicine),

Hardman & Co

Bionomics Ltd Third Phase II trial of BNC210 begins

Bionomics Ltd (ASX:BNO) is an Australian biopharmaceutical company specialising in ion channel drug discovery for central nervous system (CNS) disorders such as anxiety and post-traumatic stress disorder (PTSD). BNO also

Evgen Pharma Plc

Evgen Pharma plc analysts meeting on the 13th June

Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will announce its preliminary results for the year ended 31 March

SkinBiotherapeutics Plc

SkinBioTherapeutics plc involved in new research grant

SkinBioTherapeutics plc (LON:SBTX), a life science company focused on skin health, announced today its collaboration as industrial partner in a grant awarded by the Biotechnology and Biological Sciences Research Council (BBSRC)

Immupharma Plc

ImmuPharma PLC demonstrates more positive results

Tim McCarthy, Chairman added: “In this study Lupuzor(TM) has demonstrated a superior response rate over placebo and confirmed its exceptional safety profile. We believe this gives Lupuzor(TM) a compelling product